Cresi, Francesco
Maggiora, Elena http://orcid.org/0000-0001-7491-468X
Capetti, Cecilia
Capitanio, Martina
Ferroglio, Mattia
Spada, Elena
De Matteis, Francesca
Cosimi, Sara
Mosca, Fabio
Coscia, Alessandra
Aceti, Arianna
Amato, Orsola
Ancora, Gina
Baldassarre, Maria Elisabetta
Barone, Giovanni
Bellan, Cristina
Borgarello, Gabriella
Bottino, Roberto
Campagnoli, Francesca
Capasso, Antonella
Capretti, Maria Grazia
Carpentieri, Mauro
Cinelli, Roberto
Corvaglia, Luigi
Costa, Simonetta
Dani, Carlo
D’Amato, Gabriele
D’Andrea, Vito
Dotta, Andrea
Farina, Daniele
Ferrari, Stefania
Foglianese, Alessandra
Fracchiolla, Annalisa
Gallo, Elena
Ghirardello, Stefano
Laforgia, Nicola
Lista, Gianluca
Luciano, Mattia
Maddaloni, Chiara
Maffei, Gianfranco
Maggio, Alessandra
Maggio, Luca
Maino, Marzia
Mangili, Giovanna
Mantelli, Simona Semeria
Manzari, Raffaele
Mondello, Isabella
Natale, Maria Pia
Peila, Chiara
Petrillo, Flavia
Pivetti, Valentina
Pontiggia, Federica
Raimondi, Francesco
Romitti, Maria Grazia
Sannia, Andrea
Levet, Patrizia Savant
Savarese, Immacolata
Spagnuolo, Ferdinando
Varalda, Alessia
Villani, Paolo Ernesto
Terrin, Gianluca
Ummarino, Dario
Vento, Giovanni
,
Funding for this research was provided by:
Pall Medical part of Cytiva
Article History
Received: 16 November 2023
Accepted: 19 June 2024
First Online: 6 July 2024
Declarations
:
: The study protocol was approved with the approval number 252/2022 on 14 June 2022 by the ethics committee of the coordinating unit. The study protocol has been subsequently submitted to the ethics committees of each participating unit. Local investigators will recruit patients within 48–72 h from the beginning of infusion therapy and will gain informed consent in a written form from parents or legal guardian. This trial had been registered in ClinicalTrial.gov, NCT05537389, on 12 September 2022 before the first patient was enrolled.
: Not applicable.
: The authors declare that they have no competing interests.